What are the recommended preventive and treatment measures for fungal infections in disaster settings, including exposure avoidance, protective equipment, early diagnosis, and appropriate antifungal therapy?

Disaster Mycology: Prevention and Treatment of Fungal Infections in Disaster Settings

In disaster settings, immediately implement aggressive mold exposure reduction through protective equipment (N95 respirators minimum), early surgical debridement of contaminated wounds, and empiric antifungal therapy with liposomal amphotericin B (5-10 mg/kg/day) for suspected invasive fungal infections in trauma patients with soil-contaminated wounds, even without traditional immunocompromised risk factors. 1

Understanding the Unique Risk in Disasters

Disaster-related fungal infections differ fundamentally from typical nosocomial infections. Trauma patients in wars, explosions, and natural disasters develop invasive fungal infections (IFI) without traditional immunocompromised states due to:

• Direct inoculation of fungal spores from soil and decaying organic matter into deep tissue
• Contaminated wounds with devitalized tissue creating ideal fungal growth conditions
• Compromised healthcare infrastructure limiting sterile technique
• Delayed presentation and treatment 1, 2

Critical pitfall: Do not wait for typical risk factors (neutropenia, transplant, prolonged steroids) to consider IFI in disaster trauma patients. The mechanism is direct environmental inoculation, not opportunistic infection.

Primary Prevention Measures

Environmental Controls (Highest Priority)

Dust control is non-negotiable in any disaster medical facility or field hospital:

• HEPA filtration in patient care areas when available 3
• Physical barriers between construction/debris and patient areas
• Wet methods for debris removal to minimize aerosolization
• Immediate covering of wounds during patient transport through contaminated areas 4

Personal Protective Equipment

For healthcare workers and patients:

• N95 respirators or higher for anyone in dusty/moldy environments
• Barrier precautions during wound care in contaminated settings
• Full PPE when debriding soil-contaminated wounds 5

Patient Education

Educate trauma patients to avoid:

• Areas with visible mold growth or water damage
• Disturbing soil or decaying vegetation near wounds
• Removing dressings in unclean environments 4

Early Diagnosis Strategy

High-Risk Wound Characteristics Requiring Immediate Action

Suspect IFI when wounds show:

• Soil or organic matter contamination at injury
• Black necrotic tissue (especially concerning for mucormycosis)
• Failure to improve with antibacterial therapy
• Rapid tissue destruction despite debridement
• Angioinvasion signs (tissue ischemia, vessel thrombosis) 1

Diagnostic Approach

Do not delay treatment for diagnostic confirmation in high-risk scenarios 6:

1. Obtain tissue samples immediately during surgical debridement

   • Fresh tissue for culture (not formalin-fixed initially)
   • Send for both histopathology and fungal culture
   • Request PCR if available (higher sensitivity than culture) 4

2. Histopathology findings:

   • Mucormycosis: broad, ribbon-like, non-septate hyphae with right-angle branching
   • Aspergillosis: narrow, septate hyphae with acute-angle branching
   • Request species identification for epidemiological tracking 6

Treatment Algorithms

For Suspected Mucormycosis (Most Lethal in Disasters)

Immediate triple intervention required 6:

1. Surgical debridement - Most critical intervention

   • Complete excision of all necrotic tissue
   • Repeat every 24-48 hours until clean margins achieved
   • Do not delay for antifungal levels or imaging

2. Liposomal amphotericin B - Start immediately

   • 10 mg/kg/day IV for CNS or severe disease
   • 5 mg/kg/day for localized disease
   • Alternative: Amphotericin B lipid complex 5 mg/kg/day if liposomal unavailable
   • Posaconazole is NOT first-line treatment (only for salvage or prophylaxis)

3. Reversal of immunosuppression if applicable

   • Reduce corticosteroids first
   • Optimize diabetes control aggressively

Duration: Continue until complete resolution of all clinical and radiographic abnormalities, typically months 6

For Suspected Invasive Aspergillosis

Primary therapy 4, 7:

• Voriconazole: 6 mg/kg IV q12h × 2 doses, then 4 mg/kg IV q12h
• Alternative: Liposomal amphotericin B 3-5 mg/kg/day
• Combination therapy (voriconazole + echinocandin): Consider for severe disease, but conditional recommendation based on low-quality evidence 7

Surgical intervention mandatory for 4:

• Pulmonary lesions near great vessels or pericardium
• Chest wall invasion
• Persistent hemoptysis from cavitary lesion

Duration: Minimum 6-12 weeks, continue until radiographic resolution 4

For Invasive Candidiasis in Disaster ICU Settings

Do NOT routinely give prophylaxis to critically ill disaster patients 7. Instead, use early empiric therapy when:

• Clinical sepsis without identified source
• Multiple Candida risk factors present (central lines, broad-spectrum antibiotics, abdominal surgery, anastomotic leaks)
• Positive Candida from non-sterile sites 8

Empiric regimen 8, 9:

• Echinocandin preferred for moderately-severe illness:
  • Caspofungin: 70 mg loading, then 50 mg daily
  • Micafungin: 100 mg daily
  • Anidulafungin: 200 mg loading, then 100 mg daily
• Fluconazole 800 mg loading, then 400 mg daily for less critically ill without recent azole exposure

Mandatory interventions:

• Remove central venous catheters 8, 9
• Source control for intra-abdominal candidiasis 8
• Continue 2 weeks after blood culture clearance and symptom resolution 9

Resource-Limited Settings

When ideal antifungals unavailable 6:

For mucormycosis:

• Amphotericin B deoxycholate 1.0-1.5 mg/kg/day (expect nephrotoxicity, monitor closely)
• Surgery remains most critical intervention - prioritize aggressive debridement over optimal antifungals

For aspergillosis:

• Itraconazole 200 mg daily (oral) if voriconazole unavailable
• Amphotericin B deoxycholate 0.7-1.0 mg/kg/day 10

Critical Pitfalls to Avoid

1. Waiting for culture results: Fungal cultures take days-weeks; start empiric therapy immediately in high-risk scenarios 6, 11

2. Inadequate surgical debridement: Antifungals alone fail without source control. Repeat debridement until clean margins 6

3. Underdosing amphotericin: Use full doses (5-10 mg/kg for liposomal formulation) despite nephrotoxicity concerns - mortality from untreated mucormycosis exceeds renal toxicity risk 6

4. Using echinocandins for mold infections: Echinocandins lack activity against Aspergillus and Mucorales as monotherapy 4

5. Assuming only immunocompromised patients get IFI: Direct traumatic inoculation causes IFI in immunocompetent disaster victims 1

6. Delaying treatment for "fever of unknown origin" alone: In disasters, initiate antifungals based on wound characteristics and clinical deterioration, not just fever 6